Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 142,866	$ 0	$ 9	$ 0	$ 292,082	$ 7	$ (149,232)
Beginning balance (in shares) at Dec. 31, 2021		0	92,619,641	10,762,566
Shares issued during the period for vested restricted stock awards			$ 1		(1)
Shares issued during the period for vested restricted stock awards, shares			5,311,326
Issuance of common stock upon exercise of stock options	428				428
Issuance of common stock upon exercise of stock options, shares			1,793,876
Stock-based compensation	4,610				4,610
Net loss	(27,793)						(27,793)
Other comprehensive gain (loss)	57					57
Ending balance at Mar. 31, 2022	120,168	$ 0	$ 10	$ 0	297,119	64	(177,025)
Ending balance (in shares) at Mar. 31, 2022		0	99,724,843	10,762,566
Beginning balance at Dec. 31, 2021	142,866	$ 0	$ 9	$ 0	292,082	7	(149,232)
Beginning balance (in shares) at Dec. 31, 2021		0	92,619,641	10,762,566
Net loss	(79,112)
Ending balance at Sep. 30, 2022	81,528	$ 0	$ 10	$ 0	310,212	(350)	(228,344)
Ending balance (in shares) at Sep. 30, 2022		0	103,044,324	10,762,566
Beginning balance at Mar. 31, 2022	120,168	$ 0	$ 10	$ 0	297,119	64	(177,025)
Beginning balance (in shares) at Mar. 31, 2022		0	99,724,843	10,762,566
Shares issued during the period for vested restricted stock awards, shares			729,106
Issuance of common stock upon exercise of stock options	86				86
Issuance of common stock upon exercise of stock options, shares			266,225
Shares issued for HX Tracker acquisition, Shares			1,000,000
Shares issued for HX Tracker acquisition, Amount	4,370				4,370
Stock-based compensation	998				998
Net loss	(25,683)						(25,683)
Other comprehensive gain (loss)	60					60
Ending balance at Jun. 30, 2022	99,999	$ 0	$ 10	$ 0	302,573	124	(202,708)
Ending balance (in shares) at Jun. 30, 2022		0	101,720,174	10,762,566
Shares issued during the period for vested restricted stock awards	1,826				1,826
Shares issued during the period for vested restricted stock awards, shares			645,896
Issuance of common stock upon exercise of stock options	274				274
Issuance of common stock upon exercise of stock options, shares			678,254
Stock-based compensation	5,539				5,539
Net loss	(25,636)						(25,636)
Other comprehensive gain (loss)	(474)					(474)
Ending balance at Sep. 30, 2022	81,528	$ 0	$ 10	$ 0	310,212	(350)	(228,344)
Ending balance (in shares) at Sep. 30, 2022		0	103,044,324	10,762,566
Beginning balance at Dec. 31, 2022	66,450	$ 0	$ 11	$ 0	315,345	(61)	(248,845)
Beginning balance (in shares) at Dec. 31, 2022		0	105,032,588	10,762,566
Shares issued during the period for vested restricted stock awards	2,775				2,775
Shares issued during the period for vested restricted stock awards, shares			1,498,987
Issuance of common stock upon exercise of stock options	51				51
Issuance of common stock upon exercise of stock options, shares			265,125
Shares issued for legal settlement	2,000				2,000
Shares issued for legal settlement, shares			797,396
Sale of shares	6,292				6,292
Sale of shares, shares			2,683,000
Stock issuance costs	(32)				(32)
Stock-based compensation	2,472				2,472
Net loss	(11,762)						(11,762)
Other comprehensive gain (loss)	(5)					(5)
Ending balance at Mar. 31, 2023	68,241	$ 0	$ 11	$ 0	328,903	(66)	(260,607)
Ending balance (in shares) at Mar. 31, 2023		0	110,277,096	10,762,566
Beginning balance at Dec. 31, 2022	66,450	$ 0	$ 11	$ 0	315,345	(61)	(248,845)
Beginning balance (in shares) at Dec. 31, 2022		0	105,032,588	10,762,566
Net loss	(39,113)
Ending balance at Sep. 30, 2023	74,074	$ 0	$ 12	$ 0	362,532	(512)	(287,958)
Ending balance (in shares) at Sep. 30, 2023		0	124,954,451	10,762,566
Beginning balance at Mar. 31, 2023	68,241	$ 0	$ 11	$ 0	328,903	(66)	(260,607)
Beginning balance (in shares) at Mar. 31, 2023		0	110,277,096	10,762,566
Shares issued during the period for vested restricted stock awards	2,085				2,085
Shares issued during the period for vested restricted stock awards, shares			1,213,037
Issuance of common stock upon exercise of stock options, shares			39,087
Sale of shares	17,348		$ 1		17,347
Sale of shares, shares			6,589,000
Stock issuance costs	(127)				(127)
Stock-based compensation	2,669				2,669
Net loss	(10,414)						(10,414)
Other comprehensive gain (loss)	(408)					(408)
Ending balance at Jun. 30, 2023	79,394	$ 0	$ 12	$ 0	350,877	(474)	(271,021)
Ending balance (in shares) at Jun. 30, 2023		0	118,118,220	10,762,566
Shares issued during the period for vested restricted stock awards, shares			595,097
Issuance of common stock upon exercise of stock options	170				170
Issuance of common stock upon exercise of stock options, shares			403,749
Sale of shares	10,367				10,367
Sale of shares, shares			6,149,885
Stock issuance costs	(74)				(74)
Share repurchase and retirement (shares)			(312,500)
Stock-based compensation	1,192				1,192
Net loss	(16,937)						(16,937)
Other comprehensive gain (loss)	(38)					(38)
Ending balance at Sep. 30, 2023	$ 74,074	$ 0	$ 12	$ 0	$ 362,532	$ (512)	$ (287,958)
Ending balance (in shares) at Sep. 30, 2023		0	124,954,451	10,762,566